Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cost Effectiveness and Resource Allocation : C/E|November 21, 2018
MCDA or preference-based social welfare functions?J P SevillaJournal of Medical Economics|July 27, 2023
Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children programJ P SevillaJournal of Medical Economics|November 28, 2023
COVID-19 vaccines should be evaluated from the societal perspectiveJ P SevillaInfectious Diseases and Therapy|January 20, 2026
Taxonomy of the Full Health and Societal Value of Maternal Vaccination to Prevent Infant Respiratory Syncytial Virus DiseaseJ P Sevilla, Daria Burnes, David E BloomScience Translational Medicine|May 18, 2018
The broad socioeconomic benefits of vaccinationDavid E Bloom, Victoria Y Fan, J P SevillaProceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Toward economic evaluation of the value of vaccines and other health technologies in addressing AMRJ P Sevilla, David E Bloom, Daniel Cadarette, et al.Human Vaccines & Immunotherapeutics|January 30, 2020
Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in TurkeyJ P Sevilla, Andrew Stawasz, Daria Burnes, et al.Human Vaccines & Immunotherapeutics|September 7, 2022
Cost-utility and cost-benefit analysis of pediatric PCV programs in EgyptJ P Sevilla, Daria Burnes, Rehab Zakaria El Saie, et al.Journal of Medical Economics|March 17, 2026
The full value of mRNA seasonal influenza and endemic-stage COVID-19 combination vaccines: a taxonomyJ P Sevilla, Joseph S Knee, Daria Burnes, et al.Pageof 2